FlyteHealth Strengthens Leadership with New CEO Amid Ongoing Growth
FlyteHealth Strengthens Leadership with New CEO Amid Ongoing Growth
FlyteHealth, a prominent figure in the field of cardiometabolic care, has recently announced a key leadership transition that signals its commitment to growth and innovation. Dr. Cheryl Pegus has been appointed as the new Chief Executive Officer and Board Chair, succeeding founding CEO Sloan Saunders, who will take on the role of President.
This leadership change reflects FlyteHealth's strategic aim to enhance its market presence and amplify its impact across various sectors including employers, payors, and health systems. With Dr. Pegus taking the helm, the company is poised for an exciting chapter dedicated to advancing outcomes-driven cardiometabolic care.
Dr. Pegus, who has over three decades of diverse experience in the healthcare industry, was previously the Executive Chair at FlyteHealth where she played a pivotal role in driving growth and innovation. Her extensive background in navigating clinical and operational landscapes equips her to lead the company effectively into its next phase.
"Under the founders of FlyteHealth and the exceptional leadership of Sloan, we are positioned to address the needs of patients, support the team providing care, and build upon our strong foundation of proven success in cost-effective, engaged care," stated Dr. Pegus, expressing her enthusiasm for continuing the valuable work initiated by the founding team.
In her new role, Dr. Pegus emphasizes the importance of achieving tangible outcomes while taking a comprehensive approach to health, with a particular focus on cardiometabolic conditions that affect millions.
Sloan Saunders, as the incoming President, will collaborate closely with Dr. Pegus to advance FlyteHealth’s overarching vision. His dedication to transforming healthcare by integrating technology with personalized care will continue to be vital in this new structure. "From the beginning, we believed that healthcare could be fundamentally transformed by combining scalable technology with deeply human-centered care," Saunders said, expressing excitement for the future under Dr. Pegus's leadership.
Expanding Executive Leadership
Accompanying Dr. Pegus’s new role is the expansion of FlyteHealth's leadership team. The addition of accomplished leaders specializing in various facets of healthcare aims to bolster FlyteHealth's strategy in cardiometabolic care.
- - Cheryl Pegus, MD, MPH, Chief Executive Officer, Board Chair: Dr. Pegus brings invaluable clinical and business leadership expertise. Her prior experience includes senior roles at healthcare delivery and solution companies focused on improving patient outcomes and supporting financial sustainability. She also serves on the boards of both public and non-profit entities, showcasing her commitment to healthcare advancement.
- - Ishraf Ahmad, Chief Product and Technology Officer: With over 15 years in healthcare technology, Ishraf is known for his ability to develop and scale digital products. He has significant experience from previous roles at Virta Health and UnitedHealth Group, where he introduced AI-driven care tools and clinical platforms that benefited millions.
- - Melanie Curtice, General Counsel: Melanie has a robust track record with more than two decades of experience in healthcare law. Recognized for her strategic guidance in regulatory matters, she will ensure FlyteHealth navigates the complex legal landscape effectively.
- - Beth Baker, Senior Director of Actuarial Services: With extensive expertise in actuarial science, Beth specializes in financial analysis and innovative reimbursement models. Her contributions to the field, particularly in AI research in healthcare, complement FlyteHealth's mission.
These executive appointments are part of FlyteHealth's vision to pioneer a new era in virtual cardiometabolic care delivery, marked by integrity, operational excellence, and outcome measurement.
About FlyteHealth
FlyteHealth's innovative approaches to precision cardiometabolic care address crucial health concerns such as obesity, diabetes, hypertension, and hyperlipidemia. Utilizing data and AI technology, FlyteHealth formulates scalable treatment models that have proven to be both effective and cost-efficient. Founded by leaders in clinical obesity management, FlyteHealth combines robust clinical intelligence with smart decision-support tools. Focused on building responsive partnerships with clients, FlyteHealth is dedicated to enhancing health outcomes and fostering patient engagement—ultimately striving for sustainable improvements in care delivery.
For further information, you can visit the official website at www.flytehealth.com.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.